Eton Pharmaceuticals, Inc. (ETON) Stock Forecast
Data as of May 3, 2026Healthcare · Current price $29.06 (+20.61%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
| Date | Analyst | Firm | Price Target | Upside |
|---|---|---|---|---|
| Oct 28, 2024 | Chase Knickerbocker | Craig-Hallum | $15.00 | -48.4% |
| Oct 4, 2024 | Swayampakula Ramakanth | H.C. Wainwright | $11.00 | -62.1% |
| May 6, 2024 | Chase Knickerbocker | Craig-Hallum | $8.00 | -72.5% |
Top Analysts Covering ETON
ETON vs Sector & Market
| Metric | ETON | Healthcare Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.00 | 2.24 | 2.41 |
| Analyst Count | 5 | 8 | 18 |
| Target Upside | -14.0% | +1150.3% | +14.9% |
| P/E Ratio | -141.29 | 7.00 | 31.19 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $110M | $110M | $111M | 2 |
| 2027-03-31 | $32M | $33M | $34M | 1 |
| 2027-06-30 | $36M | $37M | $38M | 1 |
| 2027-09-30 | $37M | $39M | $40M | 1 |
| 2027-12-31 | $40M | $42M | $43M | 1 |
| 2028-03-31 | $41M | $42M | $44M | 1 |
| 2028-06-30 | $44M | $46M | $47M | 1 |
| 2028-09-30 | $46M | $48M | $49M | 1 |
| 2028-12-31 | $55M | $57M | $59M | 1 |
| 2029-12-31 | $307M | $319M | $332M | 2 |
| 2030-12-31 | $391M | $406M | $423M | 1 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $0.60 | $0.83 | $1.05 | 2 |
| 2027-03-31 | $0.30 | $0.31 | $0.32 | 1 |
| 2027-06-30 | $0.35 | $0.37 | $0.39 | 1 |
| 2027-09-30 | $0.40 | $0.42 | $0.44 | 1 |
| 2027-12-31 | $0.44 | $0.46 | $0.48 | 1 |
| 2028-03-31 | $0.43 | $0.45 | $0.47 | 1 |
| 2028-06-30 | $0.48 | $0.50 | $0.52 | 1 |
| 2028-09-30 | $0.52 | $0.55 | $0.57 | 1 |
| 2028-12-31 | $0.69 | $0.72 | $0.75 | 1 |
| 2029-12-31 | $4.15 | $4.36 | $4.59 | 1 |
| 2030-12-31 | $5.58 | $5.87 | $6.18 | 1 |
Frequently Asked Questions
What is the analyst consensus for ETON?
The consensus among 5 analysts covering Eton Pharmaceuticals, Inc. (ETON) is Buy with an average price target of $25.00.
What is the highest price target for ETON?
The highest price target for ETON is $15.00, set by Chase Knickerbocker at Craig-Hallum on 2024-10-28.
What is the lowest price target for ETON?
The lowest price target for ETON is $8.00, set by Chase Knickerbocker at Craig-Hallum on 2024-05-06.
How many analysts cover ETON?
5 analysts have issued ratings for Eton Pharmaceuticals, Inc. in the past 12 months.
Is ETON a buy or sell right now?
Based on 5 analyst ratings, ETON has a consensus rating of Buy (2.00/5) with a -14.0% upside to the consensus target of $25.00.
What are the earnings estimates for ETON?
Analysts estimate ETON will report EPS of $0.83 for the period ending 2026-12-31, with revenue estimated at $110M.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.